A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer

被引：0
|
作者：
Takashi Kobayashi
Tomonobu Koizumi
Toshihide Agatsuma
Masanori Yasuo
Kenji Tsushima
Keishi Kubo
Seiichiro Eda
Hiroshi Kuraishi
Shigeru Koyama
Tsutomu Hachiya
Nariaki Ohura
机构：
[1] Shinshu University Hospital,Comprehensive Cancer Center, Division of Clinical Oncology, Shinshu University School of Medicine
[2] Shinshu University School of Medicine,First Department of Internal Medicine
[3] Matsumoto Kyoritsu Hospital,Respiratory Division
[4] Nagano Red Cross Hospital,Respiratory Division
[5] Suwa Red Cross Hospital,Respiratory Division
[6] Saku Central Hospital,Respiratory Division
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Chemo-refractory; Salvage therapy; EGFR-sensitive mutation; Chemotherapy; NSCLC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1241 / 1246
页数：5
相关论文
共 50 条
  • [41] Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib
    Raimbourg, Judith
    Joalland, Marie-Pierre
    Cabart, Mathilde
    de Plater, Ludmilla
    Bouquet, Fanny
    Savina, Ariel
    Decaudin, Didier
    Bennouna, Jaafar
    Vallette, Francois M.
    Lalier, Lisenn
    [J]. MOLECULAR CANCER THERAPEUTICS, 2017, 16 (08) : 1634 - 1644
  • [42] PHASE II MULTICENTER TRIAL OF ERLOTINIB FOR ADVANCED NON-SMALL-CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS
    Isobe, Kazutoshi
    Homma, Sakae
    Takahashi, Kazuhisa
    Koyama, Ryo
    Mori, Kiyoshi
    Kasai, Takashi
    Tominaga, Shigeru
    Kido, Kenji
    Takaya, Hisashi
    Kishi, Kazuma
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1165 - S1166
  • [43] Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
    Passaro, Antonio
    Alesini, Daniele
    Pochesci, Alessia
    Cortesi, Enrico
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (05) : 646 - 650
  • [44] Patritumab plus Erlotinib in EGFR Wild-Type Advanced Non Small Cell Lung Cancer (NSCLC): Part a Results of HER3-Lung Study
    Paz-Arez, Luis
    Serwatowski, Piotr
    Szczesna, Aleksandra
    Von Pawel, Joachim
    Toschi, Luca
    Tibor, Csoszi
    Morabito, Alessandro
    Zhang, Ling
    Shuster, Dale
    Chen, Shuquan
    Copigneaux, Catherine
    Akerley, Wallace
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1214 - S1215
  • [45] PHASE II TRIAL OF ERLOTINIB IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER HARBORING EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS: ADDITIVE ANALYSIS OF PHARMACOKINETICS OF ERLOTINIB
    Ashizawa, Nobuyuki
    Motoshima, Kohei
    Nakamura, Yoichi
    Sano, Kazumi
    Ikegami, Yoji
    Ikeda, Takaya
    MizoguchE, Kosuke
    Takemoto, Shinnosuke
    Fukuda, Minoru
    Nagashima, Seiji
    Iida, Tetsuya
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S486 - S486
  • [46] PHASE II TRIAL OF ERLOTINIB IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER HARBORING EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS: ADDITIVE ANALYSIS OF PHARMACOKINETICS OF ERLOTINIB
    Fukushima, A.
    Motoshima, K.
    Shimada, M.
    Kitazaki, T.
    Fukuda, M.
    Hashiguchi, K.
    Nagashima, S.
    Sano, K.
    Nakamura, Y.
    Kohno, S.
    [J]. RESPIROLOGY, 2012, 17 : 81 - 81
  • [47] TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription
    Weiwei Yuan
    Wei Xu
    Yan Li
    Wei Jiang
    Yue Li
    Qiqing Huang
    Bo Chen
    Shuangshuang Wu
    Yu Wang
    Weiwei Song
    Weihong Zhao
    Jianqing Wu
    [J]. Cell Death & Disease, 10
  • [48] TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription
    Yuan, Weiwei
    Xu, Wei
    Li, Yan
    Jiang, Wei
    Li, Yue
    Huang, Qiqing
    Chen, Bo
    Wu, Shuangshuang
    Wang, Yu
    Song, Weiwei
    Zhao, Weihong
    Wu, Jianqing
    [J]. CELL DEATH & DISEASE, 2019, 10 (4)
  • [49] A single centre experience of erlotinib in unselected and wild type EGFR patients with non small cell lung cancer
    Walter, H. S.
    Ahmed, S. I.
    [J]. LUNG CANCER, 2013, 79 : S7 - S7
  • [50] A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non-Small-Cell Lung Cancer
    Goldberg, Sarah B.
    Supko, Jeffrey G.
    Neal, Joel W.
    Muzikansky, Alona
    Digumarthy, Subba
    Fidias, Panos
    Temel, Jennifer S.
    Heist, Rebecca S.
    Shaw, Alice T.
    McCarthy, Patricia O.
    Lynch, Thomas J.
    Sharma, Sreenath
    Settleman, Jeffrey E.
    Sequist, Lecia V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (10) : 1602 - 1608
12345